338 related articles for article (PubMed ID: 19416474)
21. Arf6 and its ZEB1-EPB41L5 mesenchymal axis are required for both mesenchymal- and amoeboid-type invasion of cancer cells.
Handa H; Hashimoto A; Hashimoto S; Sabe H
Small GTPases; 2018 Sep; 9(5):420-426. PubMed ID: 27754741
[TBL] [Abstract][Full Text] [Related]
22. BRAG2/GEP100/IQSec1 interacts with clathrin and regulates α5β1 integrin endocytosis through activation of ADP ribosylation factor 5 (Arf5).
Moravec R; Conger KK; D'Souza R; Allison AB; Casanova JE
J Biol Chem; 2012 Sep; 287(37):31138-47. PubMed ID: 22815487
[TBL] [Abstract][Full Text] [Related]
23. Rac3 regulates breast cancer invasion and metastasis by controlling adhesion and matrix degradation.
Donnelly SK; Cabrera R; Mao SPH; Christin JR; Wu B; Guo W; Bravo-Cordero JJ; Condeelis JS; Segall JE; Hodgson L
J Cell Biol; 2017 Dec; 216(12):4331-4349. PubMed ID: 29061650
[TBL] [Abstract][Full Text] [Related]
24. CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery.
Nam JM; Onodera Y; Mazaki Y; Miyoshi H; Hashimoto S; Sabe H
EMBO J; 2007 Feb; 26(3):647-56. PubMed ID: 17255943
[TBL] [Abstract][Full Text] [Related]
25. Co-overexpression of GEP100 and AMAP1 proteins correlates with rapid local recurrence after breast conservative therapy.
Kinoshita R; Nam JM; Ito YM; Hatanaka KC; Hashimoto A; Handa H; Otsuka Y; Hashimoto S; Onodera Y; Hosoda M; Onodera S; Shimizu S; Tanaka S; Shirato H; Tanino M; Sabe H
PLoS One; 2013; 8(10):e76791. PubMed ID: 24116160
[TBL] [Abstract][Full Text] [Related]
26. The Arf6 GEF GEP100/BRAG2 regulates cell adhesion by controlling endocytosis of beta1 integrins.
Dunphy JL; Moravec R; Ly K; Lasell TK; Melancon P; Casanova JE
Curr Biol; 2006 Feb; 16(3):315-20. PubMed ID: 16461286
[TBL] [Abstract][Full Text] [Related]
27. Machineries regulating the activity of the small GTPase Arf6 in cancer cells are potential targets for developing innovative anti-cancer drugs.
Yamauchi Y; Miura Y; Kanaho Y
Adv Biol Regul; 2017 Jan; 63():115-121. PubMed ID: 27776975
[TBL] [Abstract][Full Text] [Related]
28. NEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer.
Loskutov YV; Kozyulina PY; Kozyreva VK; Ice RJ; Jones BC; Roston TJ; Smolkin MB; Ivanov AV; Wysolmerski RB; Pugacheva EN
Oncogene; 2015 Jul; 34(28):3662-75. PubMed ID: 25241893
[TBL] [Abstract][Full Text] [Related]
29. Subunit-selective N-Methyl-d-aspartate (NMDA) Receptor Signaling through Brefeldin A-resistant Arf Guanine Nucleotide Exchange Factors BRAG1 and BRAG2 during Synapse Maturation.
Elagabani MN; Briševac D; Kintscher M; Pohle J; Köhr G; Schmitz D; Kornau HC
J Biol Chem; 2016 Apr; 291(17):9105-18. PubMed ID: 26884337
[TBL] [Abstract][Full Text] [Related]
30. Engagement of overexpressed Her2 with GEP100 induces autonomous invasive activities and provides a biomarker for metastases of lung adenocarcinoma.
Menju T; Hashimoto S; Hashimoto A; Otsuka Y; Handa H; Ogawa E; Toda Y; Wada H; Date H; Sabe H
PLoS One; 2011; 6(9):e25301. PubMed ID: 21966491
[TBL] [Abstract][Full Text] [Related]
31. Roles of Arf6 in cancer cell invasion, metastasis and proliferation.
Li R; Peng C; Zhang X; Wu Y; Pan S; Xiao Y
Life Sci; 2017 Aug; 182():80-84. PubMed ID: 28625359
[TBL] [Abstract][Full Text] [Related]
32. BRAG2a Mediates mGluR-Dependent AMPA Receptor Internalization at Excitatory Postsynapses through the Interaction with PSD-95 and Endophilin 3.
Fukaya M; Sugawara T; Hara Y; Itakura M; Watanabe M; Sakagami H
J Neurosci; 2020 May; 40(22):4277-4296. PubMed ID: 32341099
[TBL] [Abstract][Full Text] [Related]
33. GEP100/ARF6 regulates VEGFR2 signaling to facilitate high-glucose-induced epithelial-mesenchymal transition and cell permeability in retinal pigment epithelial cells.
You ZP; Chen SS; Yang ZY; Li SR; Xiong F; Liu T; Fu SH
Am J Physiol Cell Physiol; 2019 Jun; 316(6):C782-C791. PubMed ID: 30540496
[TBL] [Abstract][Full Text] [Related]
34. High expression of EPB41L5, an integral component of the Arf6-driven mesenchymal program, correlates with poor prognosis of squamous cell carcinoma of the tongue.
Otsuka Y; Sato H; Oikawa T; Onodera Y; Nam JM; Hashimoto A; Fukunaga K; Hatanaka KC; Hatanaka Y; Matsuno Y; Fukuda S; Sabe H
Cell Commun Signal; 2016 Nov; 14(1):28. PubMed ID: 27871329
[TBL] [Abstract][Full Text] [Related]
35. Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities.
Onodera Y; Hashimoto S; Hashimoto A; Morishige M; Mazaki Y; Yamada A; Ogawa E; Adachi M; Sakurai T; Manabe T; Wada H; Matsuura N; Sabe H
EMBO J; 2005 Mar; 24(5):963-73. PubMed ID: 15719014
[TBL] [Abstract][Full Text] [Related]
36. GEP100/BRAG2: activator of ADP-ribosylation factor 6 for regulation of cell adhesion and actin cytoskeleton via E-cadherin and alpha-catenin.
Hiroi T; Someya A; Thompson W; Moss J; Vaughan M
Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10672-7. PubMed ID: 16807291
[TBL] [Abstract][Full Text] [Related]
37. Arf6-driven cell invasion is intrinsically linked to TRAK1-mediated mitochondrial anterograde trafficking to avoid oxidative catastrophe.
Onodera Y; Nam JM; Horikawa M; Shirato H; Sabe H
Nat Commun; 2018 Jul; 9(1):2682. PubMed ID: 29992963
[TBL] [Abstract][Full Text] [Related]
38. P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance.
Hashimoto A; Oikawa T; Hashimoto S; Sugino H; Yoshikawa A; Otsuka Y; Handa H; Onodera Y; Nam JM; Oneyama C; Okada M; Fukuda M; Sabe H
J Cell Biol; 2016 Apr; 213(1):81-95. PubMed ID: 27044891
[TBL] [Abstract][Full Text] [Related]
39. CCL18-dependent translocation of AMAP1 is critical for epithelial to mesenchymal transition in breast cancer.
Li H; Zhang D; Yu J; Liu H; Chen Z; Zhong H; Wan Y
J Cell Physiol; 2018 Apr; 233(4):3207-3217. PubMed ID: 28834540
[TBL] [Abstract][Full Text] [Related]
40. AMPK promotes Arf6 activation in a kinase-independent manner upon glucose starvation.
Chen KJ; Hsu JW; Lee FS
J Cell Sci; 2022 Sep; 135(18):. PubMed ID: 36017701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
